![David Poulsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Poulsen
Corporate Officer/Principal presso The University of Montana
Profilo
David Poulsen is a Research Associate Professor at The University of Montana.
He was previously the Chief Scientific Officer at Sinapis Pharma, Inc. Poulsen received his undergraduate degree from Brigham Young University and his graduate and doctorate degrees from the University of Delaware.
Posizioni attive di David Poulsen
Società | Posizione | Inizio |
---|---|---|
The University of Montana | Corporate Officer/Principal | - |
Precedenti posizioni note di David Poulsen
Società | Posizione | Fine |
---|---|---|
Sinapis Pharma, Inc.
![]() Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di David Poulsen
Brigham Young University | Undergraduate Degree |
University of Delaware | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Sinapis Pharma, Inc.
![]() Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Health Technology |
- Borsa valori
- Insiders
- David Poulsen